The Role of Ferroptosis and Cuproptosis in Curcumin against Hepatocellular Carcinoma

Background: Among cancer-related deaths, hepatocellular carcinoma (HCC) ranks fourth, and traditional Chinese medicine (TCM) treatment is an important complementary alternative therapy for HCC. Curcumin is a natural ingredient extracted from <i>Curcuma longa</i> with anti-HCC activity, w...

Full description

Bibliographic Details
Published in:	Molecules
Main Authors:	Zhili Liu, Huihan Ma, Zelin Lai
Format:	Article
Language:	English
Published:	MDPI AG 2023-02-01
Subjects:	curcumin hepatocellular carcinoma ferroptosis cuproptosis
Online Access:	https://www.mdpi.com/1420-3049/28/4/1623

Similar Items

Analysis of novel therapeutic targets and construction of a prognostic model for hepatocellular carcinoma
by: Pengyuan Lei, et al.
Published: (2025-08-01)

Inhibiting the compensatory elevation of xCT collaborates with disulfiram/copper-induced GSH consumption for cascade ferroptosis and cuproptosis
by: Ping Zhang, et al.
Published: (2024-02-01)

Unveiling a cuproptosis-related risk model and the role of FARSB in hepatocellular carcinoma
by: Junlin Duan, et al.
Published: (2024-06-01)

Copper metabolism and cuproptosis: broad perspectives in the treatment of hepatocellular carcinoma
by: Jiale Liang, et al.
Published: (2025-07-01)

Nanoparticles Synergize Ferroptosis and Cuproptosis to Potentiate Cancer Immunotherapy
by: Youyou Li, et al.
Published: (2024-06-01)

Cuproplasia and cuproptosis in hepatocellular carcinoma: mechanisms, relationship and potential role in tumor microenvironment and treatment
by: Ruoyu Zhang, et al.
Published: (2025-04-01)

A cuproptosis-related lncRNA signature for predicting prognosis and immune response in hepatocellular carcinoma
by: Jingyi Wu, et al.
Published: (2023-09-01)

An 8-gene predicting survival model of hepatocellular carcinoma (HCC) related to pyroptosis and cuproptosis
by: Hongjin Wang, et al.
Published: (2023-07-01)

Identification of cuproptosis-related subtypes, cuproptosis-related gene prognostic index in hepatocellular carcinoma
by: Lei Ding, et al.
Published: (2022-09-01)

FNBP4 is a Potential Biomarker Associated with Cuproptosis and Promotes Tumor Progression in Hepatocellular Carcinoma
by: Zheng KW, et al.
Published: (2023-02-01)

Functional nanozyme system for synergistic tumor immunotherapy via cuproptosis and ferroptosis activation
by: Lina Gu, et al.
Published: (2025-03-01)

Understanding the relationship between cuproptosis and the development of hepatocellular carcinoma: implications for targeted therapies
by: Haixia Zhu, et al.
Published: (2025-03-01)

Molecular mechanisms and therapeutic strategies for ferroptosis and cuproptosis in ischemic stroke
by: Jing Wang, et al.
Published: (2024-10-01)

Cuproptosis-related genes score: A predictor for hepatocellular carcinoma prognosis, immunotherapy efficacy, and metabolic reprogramming
by: Guilin Nie, et al.
Published: (2023-02-01)

Exploring the Role of DNA Methylation Located in Cuproptosis-Related Genes: Implications for Prognosis and Immune Landscape in Hepatocellular Carcinoma
by: Rui Zhu, et al.
Published: (2024-03-01)

Relationships of Cuproptosis-Related Genes With Clinical Outcomes and the Tumour Immune Microenvironment in Hepatocellular Carcinoma
by: Xi Chen, et al.
Published: (2022-09-01)

Cuproptosis-related lncRNAs predict the clinical outcome and immune characteristics of hepatocellular carcinoma
by: Hongfei Zhu, et al.
Published: (2022-09-01)

Immunomodulation of cuproptosis and ferroptosis in liver cancer
by: Jia-qian Mo, et al.
Published: (2024-01-01)

Establishment and evaluation cuproptosis-related gene signature for predicting the prognosis and immunotherapy response of hepatocellular carcinoma
by: Shuo Wang, et al.
Published: (2025-04-01)

Bioinformatics prediction and experimental verification identify cuproptosis-related lncRNA as prognosis biomarkers of hepatocellular carcinoma
by: Zhu Liangyu, et al.
Published: (2023-09-01)

A nano-engineered approach to elicit ferroptosis/cuproptosis/apoptosis in tumor combination therapy
by: Lei Wang, et al.
Published: (2025-11-01)

Cuproptosis, ferroptosis and PANoptosis in tumor immune microenvironment remodeling and immunotherapy: culprits or new hope
by: Xiaojie Zhang, et al.
Published: (2024-11-01)

MiR-133a-5p Facilitates Cuproptosis in Hepatocellular Carcinoma Through Targeting of ATP7B
by: Ren Q, et al.
Published: (2025-05-01)

Identification of a prognostic model based on cuproptosis and ferroptosis-related genes in patients with head and neck squamous cell carcinoma
by: Yingjie Wu, et al.
Published: (2024-01-01)

Cuproptosis/ferroptosis-related gene signature is correlated with immune infiltration and predict the prognosis for patients with breast cancer
by: Jixian Li, et al.
Published: (2023-07-01)

Identification of the cuproptosis-related molecular subtypes and an immunotherapy prognostic model in hepatocellular carcinoma
by: Li Zhang, et al.
Published: (2022-11-01)

A novel cuproptosis-related prognostic gene signature and validation of differential expression in hepatocellular carcinoma
by: Yaoting Li, et al.
Published: (2023-01-01)

Exploring the synergetic role of cuproptosis and ferroptosis and their implication in advancing cancer therapeutics
by: Prashant Chauhan, et al.
Published: (2025-07-01)

Iron and copper: critical executioners of ferroptosis, cuproptosis and other forms of cell death
by: Yu Li, et al.
Published: (2023-11-01)

BIRC5 knockdown ameliorates hepatocellular carcinoma progression via regulating PPARγ pathway and cuproptosis
by: Yanxing Mai, et al.
Published: (2024-11-01)

Comprehensive analysis of cuproptosis-related lncRNAs for prognostic significance and immune microenvironment characterization in hepatocellular carcinoma
by: Duguang Li, et al.
Published: (2023-01-01)

Ferroptosis and cuproptosis in periodontitis: recent biological insights and therapeutic advances
by: Tengyi Zheng, et al.
Published: (2025-02-01)

Combining immunogenic cell death and cuproptosis to construct a prognostic signature and predict the immune status and treatment efficacy for hepatocellular carcinoma
by: Xin Feng, et al.
Published: (2024-12-01)

Tumor-targeting nanomaterials based on metal-organic frameworks mediate tumor immunotherapy by promoting cuproptosis and pyroptosis in hepatocellular carcinoma cells
by: Xiaoyuan Yi, et al.
Published: (2025-06-01)

Cuproptosis- and m6A-Related lncRNAs for Prognosis of Hepatocellular Carcinoma
by: Yuezhi Zhu, et al.
Published: (2023-08-01)

An integrative analysis revealing cuproptosis-related lncRNAs signature as a novel prognostic biomarker in hepatocellular carcinoma
by: Xilang Chen, et al.
Published: (2023-02-01)

Copper and cuproptosis-related genes in hepatocellular carcinoma: therapeutic biomarkers targeting tumor immune microenvironment and immune checkpoints
by: Xiaoqiang Wang, et al.
Published: (2023-04-01)

Tumor cuproptosis and immune infiltration improve survival of patients with hepatocellular carcinoma with a high expression of ferredoxin 1
by: Yingyao Quan, et al.
Published: (2023-06-01)

Impact of diabetes and metformin on cuproptosis and ferroptosis in breast cancer patients: an immunohistochemical analysis
by: Changwen Li, et al.
Published: (2025-04-01)

Roles and Mechanisms of Ferroptosis in Sorafenib Resistance for Hepatocellular Carcinoma
by: Liu R, et al.
Published: (2024-12-01)